יום שני, י״ד תמוז תשפ״וMonday, June 29, 2026
Follow Us
Trisol Medical Ltd., an Israeli medical device company, marked a milestone with the successful implantation of its Transcatheter Tricuspid Valve in two patients in the United States.
The effectiveness of these drugs in patients with generalized viral diseases and COVID-19, in particular, can be relatively quickly examined and made more readily available.
By Jewish News Syndicate (JNS)
The FDA has few branches outside the United States, including those in China, and several European and Latin American nations.
By JNi.Media
In Jerusalem day blindness affects 1 in every 5,000 people.
“Transcranial magnetic stimulation has shown its potential to help patients suffering from depression and headaches.”
"We are focused on executing meaningful cost reductions, rationalizing our assets and maximizing their value."
If Dr. Lichtenstein’s research pans out, patients with Alzheimer’s and Parkinson’s might also benefit.
First thwarted at the Israeli polls, now V15 funder's "healthy" bars are also losers.
By Jewish News Syndicate (JNS)
Stem cell treatment developed by Israeli company BrainStorm Cell Therapeutics has been designated by the U.S. Food and Drug Administration (FDA) as a "fast-track" treatment of amyotrophic lateral sclerosis (ALS).
The U.S. Food and Drug Administration (FDA) has granted Israeli-based Teva Pharmaceuticals full approval for Synribo, a drug that is injected for adults with a with chronic phase or accelerated phase of myeloid leukemia. Chronic myeloid leukemia, also known as chronic myelogenous leukemia, is one of four main types of leukemia and is a cancer […]
The U.S. Food and Drug Administration (FDA) has reported positive results in its Phase 2a trial of an oral insulin capsule produced by Israeli-based Oramed. The drug is for the treatment of Type 2 diabetes. The Phase 2b study will be carried out later this year, and Oramed also plans a Phase 2a study for […]
Israel’s RedHill Biopharma announced success last week in a major clinical trial of a new drug to prevent nausea in cancer patients.
June 26, 2026 
